Company News 30 Apr 2025 Orthocell Secures Health Canada Approval for Remplirâ„¢ in US$75 million Canadian Market Orthocell has secured a Medical Device Licence from Health Canada for Remplirâ„¢, opening access to the US$75 million Canadian nerve… Orthocell
Company News 28 Apr 2025 Orthocell Receives Regulatory Approval to Commence Sales of Remplirâ„¢ in US$84 million Thai market Orthocell has been granted a licence by the Food and Drug Administration of Thailand to commence sales of Remplirâ„¢ into… Orthocell
Company News 24 Apr 2025 Orthocell Appoints its First Four US Remplirâ„¢ Distributors Orthocell has appointed four US distributors for its flagship nerve repair product Remplirâ„¢, enabling the commencement of commercial distribution into… Orthocell
Video 23 Apr 2025 AusBiz | Interview with John Van Der Wielen Orthocell Chair John Van Der Wielen spoke with Ausbiz about the Company's ramp up in the US. Orthocell
Company News 09 Apr 2025 Orthocell Receives Regulatory Approval for Striate+ in Brazil Orthocell has announced that Brazilian Health Regulatory Agency, ANVISA, has granted regulatory approval for the Company’s market-leading dental membrane, Striate+â„¢,… Orthocell
Media 06 Apr 2025 MEDIA | 7 News Orthocell’s recent FDA clearance made headlines on 7 News this week, with journalist Alice Murray showcasing the human impact of… Orthocell
Media 05 Apr 2025 MEDIA | 9 News Orthocell welcomed 9 News journalist Michael Stamp to Orthocell HQ last week to film an in-depth segment about our FDA… Orthocell
Company News 04 Apr 2025 US FDA grants 510(k) clearance for Orthocell’s flagship Remplirâ„¢ nerve repair product Orthocell has announced that the US Food and Drug Administration has granted regulatory clearance under the 510(k) pathway for the… Orthocell
Company News 26 Mar 2025 First Sales of Striate+â„¢ in DACH Region Orthocell has today announced that our exclusive global distribution partner BioHorizons has officially completed first sales of Orthocell’s dental product,… Orthocell
Company News 18 Mar 2025 Orthocell Receives Regulatory Approval for Striate+ in Singapore Orthocell has received regulatory approval from Singapore's Health Sciences Authority (HSA) for its market leading dental guided bone regeneration product,… Orthocell